Peter Bystrický

475 total citations
20 papers, 370 citations indexed

About

Peter Bystrický is a scholar working on Molecular Biology, Organic Chemistry and Food Science. According to data from OpenAlex, Peter Bystrický has authored 20 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Food Science. Recurrent topics in Peter Bystrický's work include Glycosylation and Glycoproteins Research (6 papers), Mitochondrial Function and Pathology (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Peter Bystrický is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Mitochondrial Function and Pathology (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Peter Bystrický collaborates with scholars based in Slovakia, Czechia and Switzerland. Peter Bystrický's co-authors include Eva Machová, Slavomı́r Bystrický, Vladimı́r Pätoprstý, Lucia Pulzová, Ľudmila Tkáčiková, Dagmar Mudroňová, Tibor Liptaj, Anna Gvozdjáková, Vladı́mir Mlynárik and Zuzana Sumbalová and has published in prestigious journals such as The Science of The Total Environment, Carbohydrate Polymers and International Journal of Biological Macromolecules.

In The Last Decade

Peter Bystrický

20 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Bystrický Slovakia 11 165 113 85 73 35 20 370
Eugenia Pennacchietti Italy 10 250 1.5× 162 1.4× 148 1.7× 21 0.3× 46 1.3× 11 438
Alvaro I. Herrera United States 11 179 1.1× 98 0.9× 48 0.6× 118 1.6× 5 0.1× 22 433
J.H. Miller United States 6 200 1.2× 113 1.0× 81 1.0× 82 1.1× 13 0.4× 11 419
Bency Thankappan India 9 174 1.1× 123 1.1× 123 1.4× 34 0.5× 11 0.3× 16 381
Holly J. Clarke Ireland 12 67 0.4× 186 1.6× 23 0.3× 76 1.0× 24 0.7× 14 454
Abolghasem Tohidpour Russia 9 141 0.9× 110 1.0× 66 0.8× 11 0.2× 12 0.3× 13 470
Tomonori Suzuki Japan 16 201 1.2× 35 0.3× 107 1.3× 28 0.4× 26 0.7× 51 769
Xubiao Wei China 13 280 1.7× 103 0.9× 38 0.4× 45 0.6× 8 0.2× 36 482
Dipti Rai India 7 236 1.4× 78 0.7× 44 0.5× 16 0.2× 7 0.2× 13 621

Countries citing papers authored by Peter Bystrický

Since Specialization
Citations

This map shows the geographic impact of Peter Bystrický's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bystrický with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bystrický more than expected).

Fields of papers citing papers by Peter Bystrický

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bystrický. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bystrický. The network helps show where Peter Bystrický may publish in the future.

Co-authorship network of co-authors of Peter Bystrický

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bystrický. A scholar is included among the top collaborators of Peter Bystrický based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bystrický. Peter Bystrický is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bystrický, Peter, et al.. (2024). Both Enantiomers of 2-Hydroxyglutarate Modulate the Metabolism of Cultured Human Neuroblastoma Cells. Neurochemical Research. 49(9). 2480–2490. 2 indexed citations
2.
Vrana, Branislav, et al.. (2023). Examining the applicability of polar organic chemical integrative sampler for long-term monitoring of groundwater contamination caused by currently used pesticides. The Science of The Total Environment. 903. 165905–165905. 6 indexed citations
3.
Trančíková, Alžbeta, et al.. (2021). Expression of pyruvate carboxylase in cultured human astrocytoma, glioblastoma and neuroblastoma cells. General Physiology and Biophysics. 40(2). 127–135. 5 indexed citations
4.
Paulovičová, Lucia, Ema Paulovičová, Pavol Farkaš, et al.. (2019). Bioimmunological activities ofCandida glabratacellular mannan. FEMS Yeast Research. 19(2). 30 indexed citations
5.
Bystrický, Peter, Eva Machová, & Slavomı́r Bystrický. (2018). NMR comparison of hyphal and yeast Candida albicans serotype B mannans. European Biophysics Journal. 47(5). 591–596. 1 indexed citations
6.
Bystrický, Peter, Dušan Dobrota, Peter Račay, & Slavomı́r Bystrický. (2017). NMR characteristics of α-D-Man-(1→2)-D-Man and α-D-Man-(1→3)-D-Man mannobioses related to Candida albicans yeast mannan structures. Chemical Papers. 71(12). 2485–2493. 12 indexed citations
7.
Bystrický, Peter, et al.. (2015). Ultrasonic and free-radical degradation of mannan from Candida albicans. International Journal of Biological Macromolecules. 75. 32–36. 12 indexed citations
8.
Farkaš, Pavol, et al.. (2015). One-pot preparation of labelled mannan–peptide conjugate, model for immune cell processing. Glycoconjugate Journal. 33(1). 113–120. 5 indexed citations
9.
Bystrický, Peter, et al.. (2015). Exopolysaccharides of Lactobacillus reuteri : Their influence on adherence of E. coli to epithelial cells and inflammatory response. Carbohydrate Polymers. 141. 10–19. 93 indexed citations
10.
Nosálóvá, G, et al.. (2015). Fagus sylvaticaglucuronoxylan sulfatechemical profile and pharmacological view. Starch - Stärke. 68(7-8). 621–628. 1 indexed citations
11.
Bystrický, Peter, et al.. (2015). Comparative ESI FT-MS and MALDI-TOF structural analyses of representative human N-linked glycans. Chemical Papers. 69(12). 4 indexed citations
12.
Machová, Eva, Peter Bystrický, Anna Malovı́ková, & Slavomı́r Bystrický. (2014). Preparation and characterization of carboxymethyl derivatives of yeast mannans in aqueous solutions. Carbohydrate Polymers. 110. 219–223. 23 indexed citations
13.
Machová, Eva, et al.. (2014). Effect of carboxymethylation on antioxidant properties and radical degradation of mannans and glucans. Carbohydrate Polymers. 112. 603–607. 38 indexed citations
14.
Chen, Yuansha, Peter Bystrický, Pinaki Panigrahi, et al.. (2007). The capsule polysaccharide structure and biogenesis for non-O1 Vibrio cholerae NRT36S: genes are embedded in the LPS region. BMC Microbiology. 7(1). 20–20. 40 indexed citations
15.
Yi, Wen, Peter Bystrický, Qingjia Yao, et al.. (2005). Two different O-polysaccharides from Escherichia coli O86 are produced by different polymerization of the same O-repeating unit. Carbohydrate Research. 341(1). 100–108. 20 indexed citations
16.
Sumbalová, Zuzana, Peter Bystrický, Jarmila Kucharská, et al.. (2005). Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington's disease. Neurochemistry International. 48(2). 93–99. 52 indexed citations
17.
Sumbalová, Zuzana, J Horecký, Peter Bystrický, et al.. (2005). NEW MAGNETIC RESONANCE SPECTROSCOPY BIOMARKER FOR MONITORING NEURODEGENERATIVE DISEASES: ANIMAL MODELS. Biomedical Papers. 149(2). 373–376. 11 indexed citations
18.
Bystrický, Peter, et al.. (2002). Effect of gluco-monosaccharides and different conditions on digestion of hyaluronan by testicular hyaluronidase.. PubMed. 21(4). 463–9. 1 indexed citations
19.
Sumbalová, Zuzana, et al.. (2002). Effect of coenzyme Q10 on energy metabolism in aged rats with huntington's disease. Journal of Molecular and Cellular Cardiology. 34(6). A84–A84. 1 indexed citations
20.
Šoltés, Ladislav, et al.. (2001). Radical degradation of high molecular weight hyaluronan: Inhibitionof the reaction by ibuprofen enantiomers. Methods and Findings in Experimental and Clinical Pharmacology. 23(2). 65–65. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026